Home LiteratureArticle Details
PMID: 16337658 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Differential effect of losartan in female and male spontaneously hypertensive rats.

Life sciences ·Vol. 78 ·No. 19 ·2006-04-04 ·Pages 2280-5

de P Rodrigues SF, dos Santos RA, Silva-Antonialli MM, Scavone C, Nigro D, Carvalho MH, de Cássia Tostes R, Fortes ZB

Abstract

We demonstrated that the decreased response to acetylcholine observed in aorta of male and female spontaneously hypertensive rats is corrected after sustained (15 days) reduction of blood pressure levels by losartan. In order to verify if the same occurs in resistance vessels, vascular diameter changes induced by topical application of acetylcholine and bradykinin (endothelium-dependent vasodilators) and sodium nitroprusside (endothelium-independent vasodilator) to mesenteric arterioles studied in vivo, in situ were determined in rats treated with losartan for 24 h (acute) or 15 days (chronic). Rats that presented similar reduction (in %) of the blood pressure levels after losartan treatment were chosen. Sodium nitroprusside induced similar responses in losartan-treated and untreated male or female SHR. Whereas in female SHR, losartan corrected the diminished arteriolar response to endothelium-dependent vasodilators after acute and chronic treatment, in male SHR this correction only occurred after chronic treatment. Thus, losartan corrected the endothelial dysfunction more easily in female than in male SHR and independently of the normalization or the magnitude of the reduction of the blood pressure levels. In an attempt to explain the difference, we evaluated the losartan effect on nitric-oxide synthase (NOS) activity and angiotensin II AT1 and AT2 receptor gene expression in these animals. In male and female SHR, NOS activity and AT1 receptor expression were not altered by acute or chronic treatment. On the other hand, AT2 receptor expression was augmented only in female SHR by these treatments. Therefore, augmented AT2 receptor expression, but not alteration of NOS activity or AT1 receptor expression, might explain the difference observed.

MeSH Terms
Animals Antihypertensive Agents/pharmacology,therapeutic use Arterioles/drug effects,enzymology,metabolism Blood Pressure/drug effects Estrous Cycle Female Gene Expression/drug effects Hormones/blood Hypertension/drug therapy,physiopathology Losartan/pharmacology,therapeutic use Male Mesentery/blood supply,drug effects Nitric Oxide Synthase Type III/metabolism Rats Rats, Inbred SHR Receptor, Angiotensin, Type 1/genetics Receptor, Angiotensin, Type 2/genetics Sex Characteristics Vasoconstriction/drug effects
Chemicals
Antihypertensive Agents Hormones Receptor, Angiotensin, Type 1 Receptor, Angiotensin, Type 2 Nitric Oxide Synthase Type III Nos3 protein, rat Losartan
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
de P Rodrigues Stephen F
Laboratory of Hypertension, Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil.
dos Santos Rosangela A
Silva-Antonialli Michelle M
Scavone Cristóforo
Nigro Dorothy
Carvalho Maria Helena C
de Cássia Tostes Rita
Fortes Zuleica B
Article Info
Journal
Life sciences
Abbr.
Life Sci
ISSN
0024-3205
Published
2006-04-04
Epub
2005-00-06
Pages
2280-5
Language
English
Region
Netherlands
NLM ID
0375521
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]